×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Jean-Emmanuel Kurtz (ICANS Strasbourg)

18:00
Introduction du partenariat avec le Cancéropôle
Rachel Groubet (Cancéropôle Est)
 
18:05
Les ADCs Anti-HER2, mécanismes d’action & de résistance et solutions d’après
Pr Sylvain Ladoire (CGFL Dijon)
 
18:20
Les inhibiteurs de tyrosine kinase Anti-HER2, classe thérapeutique à part entière, du mécanisme d’action à l’effet thérapeutique
Pr Thierry Petit (ICANS Strasbourg)
 
 
18:35
Cas clinique/Synthèse des stratégies thérapeutiques actuelles et perspectives
Dr Isabelle Desmoulins & Pr Sylvain Ladoire (CGFL Dijon)
 
18:50
Débat/Discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-10-13
Last update : 2022-10-14

Suggestions

Thursday, December 2nd 2021 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, December 2nd 2021 from 06am to 07am (GMT-10)
San Francisco : Thursday, December 2nd 2021 from 08am to 09am (GMT-8)
New York : Thursday, December 2nd 2021 from 11am to 12pm (GMT-5)
Buenos Aires : Thursday, December 2nd 2021 from 01pm to 02pm (GMT-3)
London / Dublin : Thursday, December 2nd 2021 from 04pm to 05pm (GMT)
Paris / Berlin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
Istanbul : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+2)
Moscou / Dubaï : Thursday, December 2nd 2021 from 08pm to 09pm (GMT+4)
Bangkok : Thursday, December 2nd 2021 from 11pm to 12am (GMT+7)
Shanghai : Friday, December 3rd 2021 from 12am to 01am (GMT+8)
Tokyo : Friday, December 3rd 2021 from 01am to 02am (GMT+9)
Sydney : Friday, December 3rd 2021 from 02am to 03am (GMT+10)
Wellington : Friday, December 3rd 2021 from 04am to 05am (GMT+12)

SLNB or TAD after NAC in cN1 / ycN0 patients

Share
Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, December 21st 2021 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, December 21st 2021 from 08am to 09:30am (GMT-8)
New York : Tuesday, December 21st 2021 from 11am to 12:30pm (GMT-5)
Buenos Aires : Tuesday, December 21st 2021 from 01pm to 02:30pm (GMT-3)
London / Dublin : Tuesday, December 21st 2021 from 04pm to 05:30pm (GMT)
Paris / Berlin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Tuesday, December 21st 2021 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, December 21st 2021 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+10)
Wellington : Wednesday, December 22nd 2021 from 04am to 05:30am (GMT+12)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 06:30am to 08am (GMT-10)
San Francisco : Thursday, May 25th 2023 from 09:30am to 11am (GMT-7)
New York : Thursday, May 25th 2023 from 12:30pm to 02pm (GMT-4)
Buenos Aires : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT-3)
Reykjavik : Thursday, May 25th 2023 from 04:30pm to 06pm (GMT)
London / Dublin : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+1)
Paris / Berlin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+3)
Moscou / Dubaï : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+4)
Bangkok : Thursday, May 25th 2023 from 11:30pm to 01am (GMT+7)
Shanghai : Friday, May 26th 2023 from 12:30am to 02am (GMT+8)
Tokyo : Friday, May 26th 2023 from 01:30am to 03am (GMT+9)
Sydney : Friday, May 26th 2023 from 03:30am to 05am (GMT+11)
Wellington : Friday, May 26th 2023 from 05:30am to 07am (GMT+13)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Thursday, February 1st 2024 from 06am to 07:30am (GMT-10)
San Francisco : Thursday, February 1st 2024 from 08am to 09:30am (GMT-8)
New York : Thursday, February 1st 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Thursday, February 1st 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Thursday, February 1st 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, February 1st 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Thursday, February 1st 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Friday, February 2nd 2024 from 12am to 01:30am (GMT+8)
Tokyo : Friday, February 2nd 2024 from 01am to 02:30am (GMT+9)
Sydney : Friday, February 2nd 2024 from 02am to 03:30am (GMT+10)
Wellington : Friday, February 2nd 2024 from 04am to 05:30am (GMT+12)

Prise en charge du cancer du sein métastatique HER2-faible

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up